Concepedia

Martin R. Schneider

MR

Statistics

Publications

43

Citations

2.3K

H-Index

22

Active since

1982

Affiliations

University of Regensburg(Current)

University of Lübeck

Ludwig-Maximilians-Universität München

TE Laboratories (Ireland)

Martin R. Schneider is an author at University of Regensburg specializing in medicine, pharmacology, and oncology.

Publications per year

1982–2010

43

Publications

43

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

J M Wood, Guido Bold, Elisabeth Buchdunger et al. · PubMed · 2000 · 847 citations

, , +16

Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.

Rosemarie B. Lichtner, Andreas Menrad, Anette Sommer et al. · PubMed · 2001 · 123 citations

, , +17

Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.

Michael Schirner, Jens Hoffmann, Andreas Menrad et al. · PubMed · 1998 · 98 citations

, , +16

Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer

Jens Hoffmann, Rolf Bohlmann, N. Heinrich et al. · JNCI Journal of the National Cancer Institute · 2004 · 87 citations

, , +17

Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: Mechanistic studies

H. Michna, Martin R. Schneider, Y. Nishino et al. · Breast Cancer Research and Treatment · 1989 · 81 citations

, , +9

1–5 of 43